1Global tuberculosis control-epidemiology,strategy,financing WHO/HTM/TB/2009.411,World Health Organization(http://www.who.int)[EB].
2Doherty TM,Andersen P.Vaccines for Tuberculosis:novel concepts and recent Progress[J].Clin Microbiol Rev 2005,18(4):687-702.
3Flaherty DK,Vesosky B,Beamer GL,et al.Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination[J].J Leukoc Biol.2006,80 (6):1262-1271.
4Brandt L,Feino CJ,Weinreich OA,et al.Failure of the Mycobacterium bovis BCG vaccine:some species of environmental Mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis[J].Infect Immun.2002,70 (2):672-678.
5Andersen P.Vaccine strategies against latent tuberculosis infection[J].Trends Microbiol 2006,15 (1):7-13.
7Zhou D,Lai X,Shen Y,Sehgal P,et al.Inhibition of adaptive vgamma9elta2 T-Cell responses during active Mycobacterial coinfection of simian immunodeficiency virus SIV mac-infected monkeys[J].J Virol 2003,77 (5):2998-3006.
8Cole ST,Brosch R,Parkhill J,et al,Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence[J].Nature 1998,393 (6685):537-544.
9Camus JC,Pryor M J,Médigue C,et al.Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv[J].Microbiology 2002,148 (Pt10):2967-2973.
10McKinney JD,Hner zu Bentrup K.Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase[J].Nature 2000,406 (6797):735-738.
